Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Roila

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
New anti-emetic treatmentsF Roila, M Garassino, S Fatigoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Hematopoietic growth factors: ESMO recommendations for the applicationsJ Crawford, C Caserta, F Roila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Erythropoietins in cancer patients: ESMO recommendations for useR Greil, R Thödtman, F Roila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Management of venous thromboembolism in cancer patients: ESMO clinical recommendationsM Mandalà, A Falanga, F Roila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Methodology of antiemetic trials: a reviewM Tonato, F Roila, A Del Favero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical benefit as a primary efficacy endpointE Ballatori, A Del Favero, F Roila
Drug Safety|December 1, 1993
Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilitiesA Del Favero, F Roila, M Tonato
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Antiemetic therapy: the state of the artF Roila, E Ballatori, A Del Favero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Docetaxel as second-line chemotherapy for non-small-cell lung cancerF Roila, A Del Favero, E Ballatori
The British Journal of Cancer. Supplement|December 1, 1992
Issues in the measurement of nauseaA Del Favero, M Tonato, F Roila
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
New anti-emetic treatmentsF Roila, M Garassino, S Fatigoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Hematopoietic growth factors: ESMO recommendations for the applicationsJ Crawford, C Caserta, F Roila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Erythropoietins in cancer patients: ESMO recommendations for useR Greil, R Thödtman, F Roila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Management of venous thromboembolism in cancer patients: ESMO clinical recommendationsM Mandalà, A Falanga, F Roila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Methodology of antiemetic trials: a reviewM Tonato, F Roila, A Del Favero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical benefit as a primary efficacy endpointE Ballatori, A Del Favero, F Roila
Drug Safety|December 1, 1993
Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilitiesA Del Favero, F Roila, M Tonato
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Antiemetic therapy: the state of the artF Roila, E Ballatori, A Del Favero
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Docetaxel as second-line chemotherapy for non-small-cell lung cancerF Roila, A Del Favero, E Ballatori
The British Journal of Cancer. Supplement|December 1, 1992
Issues in the measurement of nauseaA Del Favero, M Tonato, F Roila
Pageof 12